NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Vaginal yeast infections in HIV positive women.

Williams AB, Andrews S, Frankel R, Tashima K, Mezger JA; National Conference on Women & HIV.

Natl Conf Women HIV Natl Conf Women HIV Innov Care Policy Prev 1997 Los Angel Calif. 1997 May 4-7; 182 (abstract no. P2.38).

Yale University, School of Nursing, New Haven, CT.

Objective: To describe factors associated with vulvo-vaginal candidiasis (VVC) and candida vaginitis (CV) among women with HIV infection. Methods: Baseline analysis of history, physical findings and laboratory studies of data provided by 184 HIV + women enrolled in a prospective clinical trial. VVC was defined as a vaginal swab positive for yeast without symptoms. A case of CV required the presence of symptoms, microscopic visualization of hyphae, and a vaginal swab positive for yeast. Results: The cohort was 46% African-American; 38% white; 13% Hispanic. The median age was 36 and median CD4 was 330. Seventy-five percent had a history of drug use with 34% currently using drugs. Fifty-two percent were taking anti-retroviral medication; 44% also took other antibiotics. Sixty-four women (35%) had vaginal swabs positive for yeasts; of these 52 (81%) were Candida albicans. 19 women met the case definition for CV. None of the following factors was associated with either VVC or CV: race, current illicit drug use, current antiretroviral or antibiotic use, reported condom use, self-report of current yeast infections, or vaginal pH. CV, but not VVC, was associated with age under 40 (p=.03) and CD4 less than or equal to 100 cell/mm(3) (p=.01). In a logistic regression model, only CD4 less than or equal to 100 cell/mm(3) was predictive of CV (Adjusted Odds Ratio 6.0; 95% CI 1.5, 24; p=.001). Self-report of CV was only 11% sensitive and 85% specific for current clinical disease. The predictive value of self-report was 9%. Sixty-seven percent of women felt fear or embarrassment in anticipation of pelvic examination. Discussion: Although vaginal yeast infection was common (35%) in this group, the risk for clinical disease was most dramatically increased among women with CD4 less than or equal to 100 cells/mm(3). Self-report did not adequately identify women with disease, confirming the importance of comprehensive gynecologic evaluations.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Candida albicans
  • Candidiasis, Vulvovaginal
  • Female
  • HIV Infections
  • HIV Seropositivity
  • Humans
  • Longitudinal Studies
  • Odds Ratio
  • Vulvovaginitis
Other ID:
  • 97927531
UI: 102226139

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov